Also found in: Wikipedia.
NOACNew Oral Anticoagulant
NOACNational Order of the Arrow Conference (Boy Scouts)
NOACNES on A Chip (microchip equivalent to a Nintendo Entertainment System)
NOACNaval Officers' Association of Canada (l'Association des Officiers de la Marine du Canada)
NOACNature-Of-Action Code
NOACNational Older Adult Conference (Church of the Brethren seniors conference)
NOACNational Operational Security Advisory Committee
NOACNational Operations and Automation Conference
NOACNumber of Aircraft
NOACNo Action Necessary
NOACNaval Oceaonagrapher ASW (Antisubmarine Warfare) Center (US DoD)
NOACNouvel Orchestre d'Anches et de Cuivres (French: New Concert Reeds and Brass)
References in periodicals archive ?
Simply holding the NOAC is acceptable for minor bleeding.
The FTIR spectra of NOAC and MG dye loaded NOAC are shown in figure 2 and 3 respectively.
Why not simply use warfarin instead of a costlier NOAC in addressing the problem?
If you and your doctor determine that a NOAC is the best choice for you, check with the drug manufacturers to find out more about PAPs.
This lack was quickly appreciated by the medical community because NOACs were used more and more frequently and reports of adverse events emerged.
Warfarin) will remain entrenched as first-line therapies for most of the AF and VTE patients, followed by novel oral anticoagulants (NOAC) in the developing and underdeveloped countries due to the high cost of NOAC medications.
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC Registry.
There also have been several well-conducted randomized trials--a higher quality of evidence than observational studies--in which all-cause mortality was about 10 percent lower in patients treated with NOACs compared to warfarin," he notes.
Based upon review of current literature, it does not appear likely that the FDA will approve any new NOAC antidote prior to 2016.
Due to the advances that the NOACs provide in terms of improved safety and the lack of a need for routine monitoring, NOAC uptake will continue to increase, taking market share away from vitamin K antagonists, such as warfarin.
3-6) While the lack of routine monitoring is convenient and may help to mitigate some of the costs associated with NOACs, it may be informative to measure NOAC levels in patients presenting with relatively high or low body weight, renal insufficiency (dabigatran), patients taking other medications that alter P-glycoprotein and cytochrome P3A4 metabolism, or in patient populations that were not included in NOAC clinical trials.